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ABSTRACT 
Sister Mary joseph nodule as a cutaneous marker of gastrointestinal and pelvic malignancies almost always implies 
advanced stage of malignancy with poor survival rates and palliative care as the only treatment modality in majority 
of cases. 
Keywords: Immunohistochemistry, CECT abdomen 
Introduction 
 
 
Sister Mary joseph nodule has been described as a rare 
cutaneous manifestation of advanced gastrointestinal 
and pelvic organs malignancy which almost always 
indicates a poor prognosis for the patient. We hereby 
present a case report of advanced carcinoma stomach 
with presence of this clinical sign. 
 
Case report  
 
A 70 year old male was admitted to our institute with 
complaints of dyspepsia, epigastric fullness, recurrent 
vomiting, loss of weight and apetite with on and off  
bouts of hemetemesis. On physical examination, 
patient was emaciated, pale and jaundiced. 
_______________________________ 
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On local examination abdomen was distended and  
there was a  nodular  periumbilical  mass  present 
which  was hard in consistency with irregular margins 
and fixed to abdominal wall (figure 1). On 
hematological investigations, his Hb  was found to be 
7g   and  liver function tests were deranged (SGOT  
85IU/L    SGPT  96 IU/L   ALP  109 IU/L     Total 
bilirubin to be 2.4mg/dl). His USG whole abdomen 
revealed an irregular hypodense wall thickening in 
pyloric  antrum  with loss of  gut signature .Few target 
lesions were also noted mainly in left lobe of liver 
suggestive of metastasis along with with moderate 
hepatomegaly and mild to moderate ascites. CECT 
abdomen confirmed the findings and revealed  an 
irregular circumferential  hypodense thickening in 
pyloric antrum region with maximal wall thickness of 1 
cm and length of segment  being around 3 cm with few 
enlarged lymph nodes noticed along celiac axis and 
lesser sac and multiple target lesions present in left 
lobe of liver largest of size 1.5cm. Patient underwent 
UGI endoscopy   with biopsy of lesion which on 
histopathological examination revealed poorly 
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differntiated gastric adenocarcinoma. Percutaneous 
biopsy of periumbilical mass also revealed same 
histological findings (figure 2) and thus a provisional 
diagnosis of advanced gastric carcinoma with Sister 
mary joseph nodule was made. Patient was planned to 
be put on chemotherapy and palliative care but lost 
follow up. 
 
Discussion 
 
Sister Mary joseph  nodule is rare  cutaneous 
manifestation of advanced  metastatic  malignancy 
pertaining to gastrointestinal tract mostly in males and 
pelvic organs in females however no generalizations 
can be made  and when present, it is usually an 
indication of advanced malignancy  or recurrence  
suggesting a grim prognosis for patient with average 
mean survival reported  being 10-11 months[1-3].  It 
was first reported by Sir Hamilton bailey in honour of 
Sister Mary Joseph of Mayo’s clinic who noticed 
several cases of advanced malignancy patients having 
nodular swelling in umbilical region while painting and 
draping the patients[4].  Most common malignancies 
found to have this unique presentation include those of 
stomach, ovaries, large bowel, pancreas and rarely 
lungs, breast and hematological malignancies. Though 
all malignancies are found to be in advanced stage, 
prognosis has been found to be better in nodules 
secondary to ovarian malignancy and if there is a single 
nodule.  Its mechanism is still unclear but possible  
hypothesis include direct extension from anterior 
peritoneal surface or via extensive network of vascuiar 
and lymphatic channels which umbilicus shares with 
visceral organs or  via its connection with 
embryological remnants [5,6].Clinically patient may 
present with features of swelling per se  like painful  
nodular swelling of variable hues and size ranging  
anywhere from 0.5-5 cm having hard consistency and 
irregular margins with or without  superficial 
excoriation, ulceration, fissuring and  serous or 
purulent discharge  which may  be confused with local 
cellulitis or eczema[7-9] or with features of  underlying 
malignancy  like hemetemesis, hematuria, melena, 
dyspepsia, loss of weight and apetite, anemia etc. 
Differential diagnosis include a variety of benign and 
malignant  clinical conditions  like ventral hernia, 
endometriosis, neavis, epidermal inclusion cysts, 
keloids, hypertrophic scar, seborrhic keratosis, 
umbilical granuloma, incarcerated venral hernia and 
rarely primary malignancy of umbilicus[10,11].  The 
evaluation modalities include FNAC which is cheapest 
and most easily available diagnostic  modality[12]. It is 
usually followed by percutaneous biopsy which usually 
depicts the histologial diagnosis, the most common 
being adenocarcinomas though rarely it may be 
squamous cell carcinoma, leimyoma, leiomyosarcoma 
and this may be subjected to immunohistochemical  
analysis with corresponding antibodies Most of 
umbilical metastasis have unique morphological and 
immunohistochemical properties based on which 
primary site can be found in most of the cases[13]. 
Based on clinical symptoms, patient is then subjected 
to relevant hematological and radiological  
investigations like CECT abdomen and pelvis, upper 
GI endoscopy, colonoscopy as clinical scenario may 
suggest to gauge the extent of tumour and its local and 
distal spread..Finally the modality of treatment medical 
(chemotherapy) or surgical is decided on individual 
basis as most of the cases are fairly advanced and in 
majority supportive measures and palliative care is all 
that  we  can offer to the patient  though in some 
patients depending upon site and general condition of 
the patient, life expectancy may be prolonged by 
multimodality treatment[14-15]. 
 
 
 
Figure 1: Gross appearance of sister mary joseph nodule                                                      
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Figure 2: Sister mary joseph nodule on histopathological examination 
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